Entourage Health has entered into an amended supply agreement with HEXO. The amendments extend the initial term of the agreement, securing Entourage's ongoing access to high-quality bulk cannabis biomass for its product portfolio. The prices of all products supplied under the Supply Agreement are fixed but subject to limited and periodical adjustments depending on prevailing production costs.
The amended terms follow HEXO's acquisition by Tilray, prompting Entourage to shift its sourcing strategy, now obtaining bulk cannabis from Tilray cultivation sites as needed.
"We take pride in the exceptional quality of our cannabis products," remarked George Scorsis, CEO and Chair. "Our partnership with HEXO has consistently delivered impressive results. Moving ahead with Tilray, a highly respected company, we share a common goal - to develop a partnership deeply rooted in our promise to ensure our products continue to meet and exceed the highest standard of quality and satisfaction for our patients and consumers. We are excited to work together towards this shared objective with Tilray."
For more information:
Entourage Health
information@entouragecorp.com
entouragehealthcorp.com